Pesquisar
Neurosense Therapeutics Ltd
NRSNAdicionar à lista de desejos
0.465USD
-0.011-2.27%
Fechamento 07-31 16:00（ET）Cotações atrasadas em 15 min
15.15MValor de mercado
PerdaP/L TTM
Mais detalhes de Neurosense Therapeutics Ltd Empresa
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Informações de Neurosense Therapeutics Ltd
Código da empresaNRSN
Nome da EmpresaNeurosense Therapeutics Ltd
Data de listagemDec 09, 2021
CEOBen-Noon (Alon)
Número de funcionários15
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 09
Endereço11 Hamenofim St.
CidadeHERZLIYA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal4672562
Telefone97297996183
Sitehttps://www.neurosense-tx.com/
Código da empresaNRSN
Data de listagemDec 09, 2021
CEOBen-Noon (Alon)
Executivos da empresa Neurosense Therapeutics Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Neurosense Therapeutics Ltd?
Os cinco principais acionistas de Neurosense Therapeutics Ltd são: Mr. Alon Ben-Noon
Quantas instituições possuem ações da Neurosense Therapeutics Ltd (NRSN)?
Em 2026Q1, 33 instituições possuíam ações da Neurosense Therapeutics Ltd, com valor de mercado aproximado de 367.79K, representando 1.04% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -2009158.00.